These success, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two guidance the notion of focusing on ACKR3 as a novel solution to modulate the opioid technique, which could open new therapeutic avenues for opioid-similar Issues.In reaction to this challenge, The brand